Phacoemulsification in patients with uveitis: long-term outcomes

BMC Ophthalmology

Table 2 Sub-group analysis based on uveitis etiology

PValue
	FUS	BU	IU	RDAU
Postoperative visual acuity (at 12th month)
PHU	0.259	0.436	0.263	0.952
FUS		< 0.001^a	0.123	0.785
BU			0.015^a	0.852
IU				0.403
Postoperative inflammation
PHU	0.738	0.293	0.738	0.492
FUS		0.025^a	0.380	0.297
BU			0.128	0.308
IU				0.605
Recurrence
PHU	0.738	0.293	0.738	0.492
FUS		0.016^a	0.380	0.297
BU			0.128	0.308
IU				0.605
Posterior Capsule Opacification
PHU	0.071	0.004^a	0.723	0.102
FUS		0.269	0.198	0.521
BU			0.144	0.939
IU				0.141
Cystoid Macular Edema
PHU	0.999	0.011^a	0.344	0.105
FUS		< 0.001^a	0.222	0.699
BU			0.015^a	0.383
IU				0.274
Glaucoma
PHU	0.251	0.818	0.144	0.285
FUS		0.830	0.731	0.132
BU			0.286	0.084
IU				0.184

PHU presumed herpetic uveitis, FUS Fuchs uveitis syndrome, BU Behçet uveitis, IU Idiopathic uveitis, RDAU rheumatic disease associated uveitis, ^a Statistically significant

ISSN: 1471-2415